Does New York Medicaid Cover GLP-1s? Coverage and Costs in 2026

Does New York Medicaid cover GLP-1s for weight loss?

New York Medicaid does not cover GLP-1 medications for obesity on its own. NYRx, the Medicaid Pharmacy Program run jointly by NYS DOH and Prime Therapeutics, sets coverage through a Preferred Drug List — the version in force now is dated "Revised: October 22, 2026" ⁶. It lists exactly two anti-obesity GLP-1 products, each gated behind a comorbidity most people with obesity don't have. Semaglutide (Wegovy) requires a confirmed cardiovascular-disease diagnosis plus a BMI of 40 kg/m² or higher and documented lifestyle-modification participation, capped at two treatment attempts per lifetime. Tirzepatide (Zepbound) requires the same BMI threshold and lifestyle criteria but swaps in a confirmed obstructive-sleep-apnea diagnosis, with the same two-lifetime-attempt cap ⁶.

Both are recent additions — comparing the state's own archived PDL snapshots shows the Wegovy criterion appeared between the Nov. 6, 2025 and Nov. 20, 2025 revisions ⁷⁸, and the Zepbound criterion between the June 4, 2026 and July 16, 2026 revisions ⁹¹². Neither "obesity" nor Saxenda (liraglutide's weight-loss brand) appears anywhere in the PDL's 86 pages; liraglutide is listed only as a diabetes drug ⁶.

There is no pathway for a plain obesity diagnosis (ICD-10 E66.x) without a qualifying comorbidity, and because NYRx's own materials describe "consistent management strategies across the NYRx and managed care pharmacy benefits," this restriction appears to reach Medicaid Managed Care claims too, not just fee-for-service ¹⁰. This reading comes from the PDL itself, the document NYRx publishes for prescribers, so if you are enrolled, confirm the rules that apply to you with your Medicaid plan or prescriber.

What GLP-1 care costs in New York today

Astra's price does not change inside New York, because it isn't a New York price — it's the same $68/month for semaglutide and $118/month for tirzepatide (both 12-month plans, billed as $816 and $1,416 annually) everywhere Astra operates.

New York's 2024 median household income was $85,820 (ACS 1-year estimate) ⁴ — above the national median — and the state's uninsured rate is comparatively low, around 4.9% (roughly 974,000 people) in 2024 ⁵. That means most New Yorkers priced out of GLP-1 coverage aren't uninsured outright — they're insured people whose plan excludes weight-loss drugs, or Medicaid enrollees who don't clear the comorbidity bar above.

Access and clinician supply

Telehealth removes the geography problem: a licensed clinician can manage a GLP-1 regimen for a patient anywhere in New York, from Buffalo to Long Island, without a drive to a specialist's office.

Telehealth rules in New York

In New York, physicians are licensed by the NYS Education Department's Office of the Professions ¹¹, while Medicaid pharmacy coverage, including the GLP-1 rules above, is set by the NYS Department of Health's NYRx program ⁶. Astra's clinicians see New York patients by telehealth anywhere in the state.

Availability

Astra is licensed and available across all 50 states, New York included — a resident anywhere in the state, from Buffalo to Montauk, can start care today with no state-specific eligibility restriction beyond the standard medical intake.